An in vitro and in vivo study has shown that the knockdown of ALDH6A1 can promote cancer growth and reduce response to chemotherapy cisplatin through the negative regulation of the hepatocyte nuclear factor 4 alpha (HNF4α) in bladder cancer 27. This evidence concerns the gene ALDH6A1 and urinary bladder cancer.